Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
TAK
Fundamentals

Takeda Pharmaceutical Co Ltd

TAK

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

4.58T
▲317.79B▲7.45%
12 Months Change

Assets

14.25T
▼-860.45B▼-5.70%
12 Months Change

Liabilities

7.31T
▼-522.42B▼-6.67%
12 Months Change

Free Cash Flow

856.39B
▲315.46B▲58.32%
12 Months Change

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2024-06-26
Form 20-F
ID: 0001395064-24-000086
2023-06-28
Form 20-F
ID: 0001395064-23-000072
2022-06-29
Form 20-F
ID: 0001395064-22-000107
2021-06-29
Form 20-F
ID: 0001395064-21-000140
2020-06-24
Form 20-F
ID: 0001395064-20-000110
2019-06-27
Form 20-F
ID: 0001395064-19-000005